title: Serum LP(A) levels in randomized healthy men from different European countries.
abstract: Serum lipoprotein(a) [Lp(a)], blood lipids, serum insulin and anthropometric parameters were determined in randomized samples of 38-year-old men living in six European cities: Ede (The Netherlands), Deinze (Belgium), Warsaw (Poland), Lumiar (Portugal), Verona and Naples (respectively in northern and in southern Italy). In total, 406 healthy men were studied. Serum Lp(a), blood lipids and serum insulin were measured in one laboratory. All the anthropometric and metabolic variables considered were statistically different among the participating sites, with the exception of Lp(a) serum levels. In spite of the lack of overall significant inter-center differences (Kruskal-Wallis test), the subjects from the two Italian cities had significantly lower Lp(a) serum levels than the subjects from Belgium and Portugal (Mann-Whitney U test, p < 0.01). In all cities the distribution of serum Lp(a) levels were highly skewed; the percentage of subjects with serum Lp(a) levels higher than 30 mg/dl (i.e., the commonly accepted risk level of cardiovascular disease) was 6% in both Verona and Naples (Italy), 12% in The Netherlands, 16% in Poland, 18% in Belgium and 19% in Portugal (for the last two cities, respectively, p < 0.02 and p < 0.01 vs Italian cities, chi-square test). Neither anthropometric (body mass index, waist/hip circumference ratio) nor metabolic (serum lipids and insulin) parameters showed any significant relationship with serum Lp(a) levels in any of the sites (Spearman's rank correlation). These data support the possibility of a difference in serum Lp(a) levels among different European countries.
authors.affiliation: Institute of Clinical Medicine, University of Verona, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Cigolini
authors.forename: J C
authors.initials: JC
authors.lastname: Seidell
authors.forename: M G
authors.initials: MG
authors.lastname: Zenti
authors.forename: G
authors.initials: G
authors.lastname: Bonadonna
authors.forename: L
authors.initials: L
authors.lastname: Zambelli
authors.forename: J P
authors.initials: JP
authors.lastname: Deslypere
authors.forename: F
authors.initials: F
authors.lastname: Contaldo
authors.forename: A
authors.initials: A
authors.lastname: Cruz
authors.forename: J
authors.initials: J
authors.lastname: Charzewska
authors.forename: G
authors.initials: G
authors.lastname: Targher
mesh_terms: D000328:Adult; D000886:Anthropometry; D002318:Cardiovascular Diseases / Q000097:blood / Q000453:epidemiology; D005060:Europe / Q000453:epidemiology; D006801:Humans; D007328:Insulin / Q000097:blood; D008055:Lipids / Q000097:blood; D017270:Lipoprotein(a) / Q000097:blood*; D008297:Male; D012307:Risk Factors; D016036:Seroepidemiologic Studies
chemical_list: D007328:Insulin; D008055:Lipids; D017270:Lipoprotein(a)